Global Rare Disease Diagnostics Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
出版日期：2019/07/29
頁 數：115頁
文件格式：PDF
價 格：
USD 3,480 (Single-User License)
USD 5,220 (Multi-User License)
USD 6,960 (Global-User License)
USD 5,220 (Multi-User License)
USD 6,960 (Global-User License)
Often rare diseases are chronic and life-threatening. Rare diseases can be single gene, multifactorial, chromosomal or non-genetic.
Scope of the Report:
The global Rare Disease Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rare Disease Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rare Disease Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rare Disease Diagnostics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Retrophin
3billion
23andMe
QIAGEN
Illumina
PerkinElmer
Strand Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hematology
Oncology
Market Segment by Applications, can be divided into
Hospital Laboratories
Diagnostic Laboratories
Genetic Testing Laboratories
Cancer Research Laboratories
Others
Scope of the Report:
The global Rare Disease Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rare Disease Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rare Disease Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rare Disease Diagnostics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Retrophin
3billion
23andMe
QIAGEN
Illumina
PerkinElmer
Strand Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hematology
Oncology
Market Segment by Applications, can be divided into
Hospital Laboratories
Diagnostic Laboratories
Genetic Testing Laboratories
Cancer Research Laboratories
Others
Table of Contents
1 Rare Disease Diagnostics Market Overview
1.1 Product Overview and Scope of Rare Disease Diagnostics
1.2 Classification of Rare Disease Diagnostics by Types
1.2.1 Global Rare Disease Diagnostics Revenue Comparison by Types (2019-2024)
1.2.2 Global Rare Disease Diagnostics Revenue Market Share by Types in 2018
1.2.3 Hematology
1.2.4 Oncology
1.3 Global Rare Disease Diagnostics Market by Application
1.3.1 Global Rare Disease Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Laboratories
1.3.3 Diagnostic Laboratories
1.3.4 Genetic Testing Laboratories
1.3.5 Cancer Research Laboratories
1.3.6 Others
1.4 Global Rare Disease Diagnostics Market by Regions
1.4.1 Global Rare Disease Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.5 Global Market Size of Rare Disease Diagnostics (2014-2024)
2 Manufacturers Profiles
2.1 Retrophin
2.1.1 Business Overview
2.1.2 Rare Disease Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.2 3billion
2.2.1 Business Overview
2.2.2 Rare Disease Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.3 23andMe
2.3.1 Business Overview
2.3.2 Rare Disease Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.4 QIAGEN
2.4.1 Business Overview
2.4.2 Rare Disease Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Illumina
2.5.1 Business Overview
2.5.2 Rare Disease Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.6 PerkinElmer
2.6.1 Business Overview
2.6.2 Rare Disease Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Strand Life Sciences
2.7.1 Business Overview
2.7.2 Rare Disease Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rare Disease Diagnostics Market Competition, by Players
3.1 Global Rare Disease Diagnostics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rare Disease Diagnostics Players Market Share
3.2.2 Top 10 Rare Disease Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Rare Disease Diagnostics Market Size by Regions
4.1 Global Rare Disease Diagnostics Revenue and Market Share by Regions
4.2 North America Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.3 Europe Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.5 South America Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
5 North America Rare Disease Diagnostics Revenue by Countries
5.1 North America Rare Disease Diagnostics Revenue by Countries (2014-2019)
5.2 USA Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
5.3 Canada Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
5.4 Mexico Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6 Europe Rare Disease Diagnostics Revenue by Countries
6.1 Europe Rare Disease Diagnostics Revenue by Countries (2014-2019)
6.2 Germany Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.3 UK Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.4 France Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.5 Russia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.6 Italy Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rare Disease Diagnostics Revenue by Countries
7.1 Asia-Pacific Rare Disease Diagnostics Revenue by Countries (2014-2019)
7.2 China Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.3 Japan Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.4 Korea Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.5 India Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
8 South America Rare Disease Diagnostics Revenue by Countries
8.1 South America Rare Disease Diagnostics Revenue by Countries (2014-2019)
8.2 Brazil Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
8.3 Argentina Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
8.4 Colombia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rare Disease Diagnostics by Countries
9.1 Middle East and Africa Rare Disease Diagnostics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.3 UAE Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.4 Egypt Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.6 South Africa Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
10 Global Rare Disease Diagnostics Market Segment by Type
10.1 Global Rare Disease Diagnostics Revenue and Market Share by Type (2014-2019)
10.2 Global Rare Disease Diagnostics Market Forecast by Type (2019-2024)
10.3 Hematology Revenue Growth Rate (2014-2024)
10.4 Oncology Revenue Growth Rate (2014-2024)
11 Global Rare Disease Diagnostics Market Segment by Application
11.1 Global Rare Disease Diagnostics Revenue Market Share by Application (2014-2019)
11.2 Rare Disease Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Laboratories Revenue Growth (2014-2019)
11.4 Diagnostic Laboratories Revenue Growth (2014-2019)
11.5 Genetic Testing Laboratories Revenue Growth (2014-2019)
11.6 Cancer Research Laboratories Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)
12.1 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)
12.2 Global Rare Disease Diagnostics Market Forecast by Regions (2019-2024)
12.3 North America Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.4 Europe Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.6 South America Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
1 Rare Disease Diagnostics Market Overview
1.1 Product Overview and Scope of Rare Disease Diagnostics
1.2 Classification of Rare Disease Diagnostics by Types
1.2.1 Global Rare Disease Diagnostics Revenue Comparison by Types (2019-2024)
1.2.2 Global Rare Disease Diagnostics Revenue Market Share by Types in 2018
1.2.3 Hematology
1.2.4 Oncology
1.3 Global Rare Disease Diagnostics Market by Application
1.3.1 Global Rare Disease Diagnostics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Laboratories
1.3.3 Diagnostic Laboratories
1.3.4 Genetic Testing Laboratories
1.3.5 Cancer Research Laboratories
1.3.6 Others
1.4 Global Rare Disease Diagnostics Market by Regions
1.4.1 Global Rare Disease Diagnostics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Disease Diagnostics Status and Prospect (2014-2024)
1.5 Global Market Size of Rare Disease Diagnostics (2014-2024)
2 Manufacturers Profiles
2.1 Retrophin
2.1.1 Business Overview
2.1.2 Rare Disease Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.2 3billion
2.2.1 Business Overview
2.2.2 Rare Disease Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.3 23andMe
2.3.1 Business Overview
2.3.2 Rare Disease Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.4 QIAGEN
2.4.1 Business Overview
2.4.2 Rare Disease Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Illumina
2.5.1 Business Overview
2.5.2 Rare Disease Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.6 PerkinElmer
2.6.1 Business Overview
2.6.2 Rare Disease Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Strand Life Sciences
2.7.1 Business Overview
2.7.2 Rare Disease Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rare Disease Diagnostics Market Competition, by Players
3.1 Global Rare Disease Diagnostics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rare Disease Diagnostics Players Market Share
3.2.2 Top 10 Rare Disease Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Rare Disease Diagnostics Market Size by Regions
4.1 Global Rare Disease Diagnostics Revenue and Market Share by Regions
4.2 North America Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.3 Europe Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.5 South America Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
5 North America Rare Disease Diagnostics Revenue by Countries
5.1 North America Rare Disease Diagnostics Revenue by Countries (2014-2019)
5.2 USA Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
5.3 Canada Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
5.4 Mexico Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6 Europe Rare Disease Diagnostics Revenue by Countries
6.1 Europe Rare Disease Diagnostics Revenue by Countries (2014-2019)
6.2 Germany Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.3 UK Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.4 France Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.5 Russia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
6.6 Italy Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rare Disease Diagnostics Revenue by Countries
7.1 Asia-Pacific Rare Disease Diagnostics Revenue by Countries (2014-2019)
7.2 China Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.3 Japan Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.4 Korea Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.5 India Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
8 South America Rare Disease Diagnostics Revenue by Countries
8.1 South America Rare Disease Diagnostics Revenue by Countries (2014-2019)
8.2 Brazil Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
8.3 Argentina Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
8.4 Colombia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rare Disease Diagnostics by Countries
9.1 Middle East and Africa Rare Disease Diagnostics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.3 UAE Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.4 Egypt Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
9.6 South Africa Rare Disease Diagnostics Revenue and Growth Rate (2014-2019)
10 Global Rare Disease Diagnostics Market Segment by Type
10.1 Global Rare Disease Diagnostics Revenue and Market Share by Type (2014-2019)
10.2 Global Rare Disease Diagnostics Market Forecast by Type (2019-2024)
10.3 Hematology Revenue Growth Rate (2014-2024)
10.4 Oncology Revenue Growth Rate (2014-2024)
11 Global Rare Disease Diagnostics Market Segment by Application
11.1 Global Rare Disease Diagnostics Revenue Market Share by Application (2014-2019)
11.2 Rare Disease Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Laboratories Revenue Growth (2014-2019)
11.4 Diagnostic Laboratories Revenue Growth (2014-2019)
11.5 Genetic Testing Laboratories Revenue Growth (2014-2019)
11.6 Cancer Research Laboratories Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)
12.1 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)
12.2 Global Rare Disease Diagnostics Market Forecast by Regions (2019-2024)
12.3 North America Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.4 Europe Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.6 South America Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rare Disease Diagnostics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
